EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -1.413
March 31, 2026 -1.456
December 31, 2025 -1.438
September 30, 2025 -1.436
June 30, 2025 -1.278
March 31, 2025 -1.149
December 31, 2024 -1.262
September 30, 2024 -1.320
June 30, 2024 -1.355
March 31, 2024 -1.356
December 31, 2023 -1.256
September 30, 2023 -1.112
June 30, 2023 -1.173
March 31, 2023 -1.155
December 31, 2022 -0.9859
September 30, 2022 -1.010
June 30, 2022 -0.9305
March 31, 2022 -0.9365
December 31, 2021 -0.9524
September 30, 2021 -1.939
June 30, 2021 -1.894
March 31, 2021 -2.278
December 31, 2020 -2.454
September 30, 2020 -1.778
June 30, 2020 -2.034
Date Value
March 31, 2020 -1.967
December 31, 2019 -2.005
September 30, 2019 -1.892
June 30, 2019 -1.831
March 31, 2019 -1.631
December 31, 2018 -1.578
September 30, 2018 -1.595
June 30, 2018 -1.75
March 31, 2018 -2.02
December 31, 2017 -2.20
September 30, 2017 -2.28
June 30, 2017 -2.13
March 31, 2017 -1.95
December 31, 2016 -1.81
September 30, 2016 -1.72
June 30, 2016 -1.80
March 31, 2016 -1.79
December 31, 2015 -1.70
September 30, 2015 -1.64
June 30, 2015 -1.65
March 31, 2015 -3.30
December 31, 2014 -3.279
September 30, 2014 -4.099
June 30, 2014 -4.099
March 31, 2014 -1.999

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
EyePoint, Inc. -3.744
ANI Pharmaceuticals, Inc. 4.632
Eli Lilly & Co. 29.43
Corcept Therapeutics, Inc. 0.4187
Veru, Inc. -0.6109